1. Guang, S, O'Brien, B M, Fine, A S, Fatemi, A, Nemeth, C L. 2023. Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing. In Scientific reports, 13, 13042. doi:10.1038/s41598-023-40107-7. https://pubmed.ncbi.nlm.nih.gov/37563224/
2. Jiang, Yingfeng, You, Jianbin, Wu, Chuncai, Chen, Liangyuan, Wu, Wenbing. 2022. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma. In Journal of clinical laboratory analysis, 36, e24691. doi:10.1002/jcla.24691. https://pubmed.ncbi.nlm.nih.gov/36085578/
3. Liu, Xu-Sheng, Zeng, Jing, Zhang, Yao-Hua, Liu, Chao, Pei, Zhi-Jun. 2023. DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma. In American journal of cancer research, 13, 818-834. doi:. https://pubmed.ncbi.nlm.nih.gov/37034224/
4. Fang, Tao, Jiang, Jin, Yu, Wenhao, Li, Rongyang, Tian, Hui. 2023. DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway. In Thoracic cancer, 14, 3511-3521. doi:10.1111/1759-7714.15152. https://pubmed.ncbi.nlm.nih.gov/37950542/
5. Rumyantseva, Anastasia, Motori, Elisa, Trifunovic, Aleksandra. . DARS2 is indispensable for Purkinje cell survival and protects against cerebellar ataxia. In Human molecular genetics, 29, 2845-2854. doi:10.1093/hmg/ddaa176. https://pubmed.ncbi.nlm.nih.gov/32766765/
智鼠故事 
